Answers are grounded in this paper and cite their sources.
AMA Wojtasik-Bakalarz K, Siwek M. New antipsychotic medication. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2023;39(1):19-38. doi:10.5114/fpn.2022.124608. APA Wojtasik-Bakalarz, K., & Siwek, M. (2023). New antipsychotic medication. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 39(1), 19-38. https://doi.org/10.5114/fpn.2022.124608 Chicago Wojtasik-Bakalarz, Krzysztof, and Marcin Siwek. 2023. "New antipsychotic medication". Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii 39 (1): 19-38. doi:10.5114/fpn.2022.124608. Harvard Wojtasik-Bakalarz, K., and Siwek, M. (2023). New antipsychotic medication. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, 39(1), pp.19-38. https://doi.org/10.5114/fpn.2022.124608 MLA Wojtasik-Bakalarz, Krzysztof et al. "New antipsychotic medication." Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii, vol. 39, no. 1, 2023, pp. 19-38. doi:10.5114/fpn.2022.124608. Vancouver Wojtasik-Bakalarz K, Siwek M. New antipsychotic medication. Pharmacotherapy in Psychiatry and Neurology/Farmakoterapia w Psychiatrii i Neurologii. 2023;39(1):19-38. doi:10.5114/fpn.2022.124608.
No takes yet. Share an insight, caveat, or question.
Wojtasik-Bakalarz et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: